After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer ...
The FDA should be more open and collaborative to unleash a surge in approvals of rare disease drugs, according to a report by ...
The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...
For Intercept Pharmaceuticals’ beleaguered liver disease drug Ocaliva, the hits just keep coming. | Ahead of an advisory ...
Sarfaraz K. Niazi, PhD, explains the FDA's new guidelines on post-approval changes for biosimilars, emphasizing the processes ...
Calley Means, co-founder of TruMed, recently raised concerns about conflicts of interest within the FDA and the influence of ...
Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...
Elon Musk's brain-chip startup has just received its first big win, the breakthrough device, experimental implant, Blindsight ...
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
and then scale up and expand successful programs and modify or sunset those that are not improving the regulatory process. Much of the data to support licensure applications for new drugs submitted ...